Dingemanse J - Search Results

1

Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327.

Bench CJ, Price GW, Lammertsma AA, Cremer JC, Luthra SK, Turton D, Dolan RJ, Kettler R, Dingemanse J, Da Prada M, et al. Bench CJ, et al. Among authors: dingemanse j. Eur J Clin Pharmacol. 1991;40(2):169-73. doi: 10.1007/BF00280072. Eur J Clin Pharmacol. 1991. PMID: 1906004 Clinical Trial.

2

MAO-B inhibition in rabbit tissues and in human platelets by Ro 19-6327 shows similar time-course.

Kettler R, Cesura AM, Dingemanse J, Da Prada M. Kettler R, et al. Among authors: dingemanse j. J Neural Transm Suppl. 1990;32:211-4. doi: 10.1007/978-3-7091-9113-2_31. J Neural Transm Suppl. 1990. PMID: 2089093

3

Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans.

Dingemanse J, Jorga KM, Schmitt M, Gieschke R, Fotteler B, Zürcher G, Da Prada M, van Brummelen P. Dingemanse J, et al. Clin Pharmacol Ther. 1995 May;57(5):508-17. doi: 10.1016/0009-9236(95)90035-7. Clin Pharmacol Ther. 1995. PMID: 7768073 Clinical Trial.

4

Mixed linear and non-linear disposition of lazabemide, a reversible and selective inhibitor of monoamine oxidase B.

Guentert TW, Holford NH, Pfefen JP, Dingemanse J. Guentert TW, et al. Among authors: dingemanse j. Br J Clin Pharmacol. 1994 Jun;37(6):545-51. doi: 10.1111/j.1365-2125.1994.tb04302.x. Br J Clin Pharmacol. 1994. PMID: 7917772 Free PMC article. Clinical Trial.

5

Pharmacodynamics of lazabemide, a reversible and selective inhibitor of monoamine oxidase B.

Holford NH, Guentert TW, Dingemanse J, Kettler R. Holford NH, et al. Among authors: dingemanse j. Br J Clin Pharmacol. 1994 Jun;37(6):553-7. doi: 10.1111/j.1365-2125.1994.tb04303.x. Br J Clin Pharmacol. 1994. PMID: 7917773 Free PMC article. Clinical Trial.

6

Potent COMT inhibition by Ro 40-7592 in the periphery and in the brain. Preclinical and clinical findings.

Zürcher G, Dingemanse J, Da Prada M. Zürcher G, et al. Among authors: dingemanse j. Adv Neurol. 1993;60:641-7. Adv Neurol. 1993. PMID: 8420203 No abstract available.

7

Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa.

Dingemanse J, Jorga K, Zürcher G, Schmitt M, Sedek G, Da Prada M, Van Brummelen P. Dingemanse J, et al. Br J Clin Pharmacol. 1995 Sep;40(3):253-62. doi: 10.1111/j.1365-2125.1995.tb05781.x. Br J Clin Pharmacol. 1995. PMID: 8527287 Free PMC article. Clinical Trial.

8

Assessment of catechol-O-methyltransferase activity and its inhibition in erythrocytes of animals and humans.

Zürcher G, Da Prada M, Dingemanse J. Zürcher G, et al. Among authors: dingemanse j. Biomed Chromatogr. 1996 Jan-Feb;10(1):32-6. doi: 10.1002/(SICI)1099-0801(199601)10:1<32::AID-BMC550>3.0.CO;2-N. Biomed Chromatogr. 1996. PMID: 8821869

9

Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.

Dingemanse J, Kneer J, Wallnöfer A, Kettler R, Zürcher G, Koulu M, Korn A. Dingemanse J, et al. Clin Neuropharmacol. 1996 Oct;19(5):399-414. doi: 10.1097/00002826-199619050-00003. Clin Neuropharmacol. 1996. PMID: 8889283 Clinical Trial.

10

Pharmacokinetics and pharmacodynamics of single and multiple doses of the MAO-B inhibitor lazabemide in healthy subjects.

Dingemanse J, Wood N, Jorga K, Kettler R. Dingemanse J, et al. Br J Clin Pharmacol. 1997 Jan;43(1):41-7. Br J Clin Pharmacol. 1997. PMID: 9056051 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

334 results

Search Page